Bank of Montreal’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bank of Montreal’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-109,339	Closed	-$596K	–	4306
2022 Q4	$596K	Buy	+109,339	New	+$916K	﹤0.01%	2513
2021 Q2	–	Sell	-1,107	Closed	-$28K	–	5084
2021 Q1	$28K	Sell	1,107 -4,178	-79%	-$97.1K	﹤0.01%	3934
2020 Q4	$99K	Buy	5,285 +3,711	+236%	+$55.4K	﹤0.01%	3592
2020 Q3	$19K	Sell	1,574 -1,148	-42%	-$18.9K	﹤0.01%	3866
2020 Q2	$58K	Buy	+2,722	New	+$45K	﹤0.01%	3369
2020 Q1	–	Sell	-4,264	Closed	-$113K	–	4832
2019 Q4	$113K	Buy	4,264 +1,296	+44%	+$30.3K	﹤0.01%	3436
2019 Q3	$68K	Buy	2,968 +157	+6%	+$4.95K	﹤0.01%	3492
2019 Q2	$86K	Buy	2,811 +2,808	+93,600%	+$59.1K	﹤0.01%	3438
2019 Q1	$0	Sell	3 -318	-99%	-$6.03K	﹤0.01%	4832
2018 Q4	$6K	Buy	321 +177	+123%	+$6.63K	﹤0.01%	4057
2018 Q3	$8K	Sell	144 -1	-0.7%	-$55	﹤0.01%	4007
2018 Q2	$6K	Buy	+145	New	+$6.21K	﹤0.01%	4097

Other funds holding GTHX

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of Montreal's GTHX Position: Q1 2023 in Review

Bank of Montreal sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2023, closing a stake of 109,339 shares — an estimated $596K sold.

Bank of Montreal first reported a position in GTHX in Q2 2018 and held it in 12 quarters. The position peaked at $596K in Q4 2022. 96 funds tracked by Wall St. Rank hold GTHX as of Q1 2023.

Bank of Montreal reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bank of Montreal sold 109,339 G1 Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $596K.
Bank of Montreal first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
Bank of Montreal's G1 Therapeutics, Inc. Common Stock position peaked at $596K in Q4 2022.
96 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.